Idera Pharmaceuticals(美国)

Idera Pharma

美国IderaPharmaceuticalswww.iderapharma.comIderaPharmaceuticalsdevelopsdrugcandidatestotreatinfectiousdiseases,autoimmuneandinflammatorydiseases,cancer,andrespiratorydiseases,andforuseasvaccineadjuvants .OurproprietarydrugcandidatesaredesignedtomodulatespecificToll-likeReceptors(TLRs),whichareafamilyofimmunesystemreceptorsthatdirectimmunesystemresponses.OurpioneeringDNAandRNAchemistryexpertiseenablesustocreatedrugcandidatesforourinternaldevelopmentprogramsandourpartneredprograms,andgeneratesopportunitiesforadditionalcollaborativealliances.Wehavethreedrugcandidatesinclinicaldevelopmentandmultiplepreclinicalstageprograms:IMO-2055inclinicaldevelopmentforcancertreatment(licensee:MerckKGaA)IMO-2125inclinicaldevelopmentforhepatitisCvirusinfectionQAX935(IMO-2134)inclinicaldevelopmentforasthmaandallergies(licensee:Novartis)IMO